United States · FDA National Drug Code directory

OMALIZUMAB

Source ingredient · 11 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.

United States · Source reference 72606-035_89c265ef-7a29-46f4-aaa1-88ab318e30b9

OMLYCLO

INJECTION / CELLTRION USA, Inc.

United States · Source reference 72606-036_89c265ef-7a29-46f4-aaa1-88ab318e30b9

OMLYCLO

INJECTION / CELLTRION USA, Inc.

United States · Source reference 72606-054_89c265ef-7a29-46f4-aaa1-88ab318e30b9

OMLYCLO

INJECTION / CELLTRION USA, Inc.

United States · Source reference 50242-040_48785e56-4828-4f55-88e1-eca2cb88299d

XOLAIR

INJECTION, SOLUTION / Genentech, Inc.

United States · Source reference 50242-227_48785e56-4828-4f55-88e1-eca2cb88299d

Xolair

INJECTION, SOLUTION / Genentech, Inc.

United States · Source reference 50242-214_48785e56-4828-4f55-88e1-eca2cb88299d

Xolair PFS

INJECTION, SOLUTION / Genentech, Inc.

United States · Source reference 50242-215_48785e56-4828-4f55-88e1-eca2cb88299d

Xolair PFS

INJECTION, SOLUTION / Genentech, Inc.

United States · Source reference 17088-0268_9d4e9303-e65f-4ae5-9c78-1a9b665262dd

omalizumab

INJECTION, SOLUTION / Novartis Pharma Stein AG

United States · Source reference 17088-0275_9d4e9303-e65f-4ae5-9c78-1a9b665262dd

omalizumab

INJECTION, SOLUTION / Novartis Pharma Stein AG

United States · Source reference 17088-0282_9d4e9303-e65f-4ae5-9c78-1a9b665262dd

omalizumab

INJECTION, SOLUTION / Novartis Pharma Stein AG

United States · Source reference 17088-0386_67bbe202-283e-46bf-9843-6a28ace9d9fc

omalizumab

INJECTION, SOLUTION / Novartis Pharma Stein AG

Browse ingredients in United States →
OMALIZUMAB | Molindra Medicines